Pacific Biosciences Of California reported $1.82B in Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Accelerate Diagnostics AXDX:US USD 75.85M 17.12M
Agilent A:US USD 10.52B 32M
Bruker BRKR:US USD 3.34B 47.9M
Danaher DHR:US USD 81.03B 776M
Fluidigm FLDM:US USD 414.92M 26.21M
General Electric GE:US USD 180.88B 4.66B
Illumina ILMN:US USD 11.26B 4.19B
Myriad Genetics MYGN:US USD 1.21B 1.8M
Nanostring Technologies NSTG:US USD 383.6M 29.78M
Pacific Biosciences Of California PACB:US USD 1.82B 57.19M
Perkinelmer PKI:US USD 13.82B 365.94M
Quidel QDEL:US USD 8.66B 166.9M
Thermo Fisher Scientific TMO:US USD 90.54B 43M
Waters WAT:US USD 3.07B 29.48M